We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Novel IV Catheter with Multi-Access Blood Control Reduces Risk of Bloodborne Pathogen Exposure

By HospiMedica International staff writers
Posted on 12 Oct 2023

Getting intravenous (IV) access is a key part of infusion therapy, and healthcare professionals are still at risk for needlestick injuries. More...

These injuries can expose them to infections from bloodborne pathogens. Research has indicated that fully automatic safety devices are twice as effective as semi-automatic push-button shields and three times more effective than manually operated sliding shields in preventing needlestick injuries. Now, a new IV catheter with multi-access blood control and fully automatic safety features aims to offer enhanced protection to clinicians whenever they access the catheter hub.

B. Braun Medical (Melsungen, Germany) has launched its new Introcan Safety 2 IV Catheter which comes with multi-access blood control. This new catheter is part of B. Braun's continuing efforts to develop catheters that minimize needlestick injuries. What sets this catheter apart is that it not only provides automatic protection against needlestick injuries but also includes a feature that protects from blood exposure each time the catheter hub is accessed. This lowers the chance of exposure to bloodborne pathogens throughout the IV procedure.

Another concern besides needlestick injuries is the risk of blood exposure from spillage when accessing the catheter hub. Catheters with blood control features have been proven to significantly cut down on the risk of blood exposure as well as the time and effort needed for cleanup. Survey results also suggest possible cost savings in terms of time and supplies needed for cleaning up blood spills. The Introcan Safety 2 Catheter's multi-access blood control feature is designed to work repeatedly, reducing the risk of blood exposure and spillage during the entire IV process.

"Appropriate device selection is key to achieving successful PIVC outcomes," said Chad Laity, Director of Marketing, Vascular Access, IV Systems and Securement. "The newly launched Introcan Safety 2 IV Catheter with Multi-Access Blood Control provides clinicians with another option when choosing the right device for their patients. When combined with our Peripheral Advantage Program, our technology and solutions are designed to facilitate the best possible outcomes around vascular access care."

Related Links:
B. Braun Medical 


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.